ABBV · News · 20260804N
Outstanding Indebtedness
AbbVie Inc. · 2026-08-04 · Importance 64 · Surprise 42 · In source text
AbbVie launched a $10 billion bond sale to finance its pending Apogee Therapeutics acquisition. Earlier reporting indicated the company was seeking to raise at least $8 billion in debt for the transaction. The debt financing will increase leverage to fund the approximately $10.9 billion acquisition.
Key facts
- AbbVie reportedly is seeking to raise at least $8 billion in debt to finance its acquisition of Apogee Therapeutics. source
- AbbVie Inc. has initiated a $10 billion bond sale to finance its acquisition of Apogee Therapeutics. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| liability | negative | probable | — | AbbVie Inc. has initiated a $10 billion bond sale to finance its acquisition of Apogee Therapeutics. |